Food and Drug Administration recently issued a warning against using unapproved GLP-1 drugs for weight loss, citing quality concerns, false or misleading labels, counterfeit drugs and more than 1,600 reports of adverse effects associated with compounded GLP-1 medications
MEDI7247 entered phase I clinical trials for treating hematological malignancies (NCT03106428 and NCT03811652) (Hartley, 2021
6(12):94453 Cawley J, Biener A, Meyerhoefer C, Ding Y, Zvenyach T, Smolarz BG et al (2021) Direct medical costs of obesity in the United States and the most populous states
Eur J Neurosci 22(7):15701580 Bansal N, Farley NJ, Wu L, Lewis J, Youssoufian H, Bertino JR (2015) Darinaparsin inhibits prostate tumorinitiating cells and Du145 xenografts and is an inhibitor of Hedgehog signaling
Our company is an export enterprise focusing on health care products, chemical materials, metal materials and hardware products